November 17, 2026 · Journal of clinical oncology : official journal of the American Society of Clinical Oncology · DOI: 10.1200/JCO-26-00969

Partial-Breast Irradiation Versus Whole-Breast Irradiation for Low-Risk Invasive Breast Carcinoma: 5-Year Results of the Multicenter, Randomized, Phase III IRMA Trial.

Listen to this summary

The IRMA trial asked whether external-beam accelerated partial-breast irradiation (38.5 Gy in 10 twice-daily fractions) gives local control noninferior to whole-breast irradiation in low-risk invasive breast cancer patients. In 3,309 randomized women followed for a median of 97.5 months, 5-year ipsilateral breast tumor recurrence was very low in both arms (1.0% APBI vs 0.8% WBI, HR 1.18). Because the upper confidence limit (2.20) crossed the prespecified noninferiority margin of 1.5, formal noninferiority was not demonstrated, though the authors conclude APBI is a reasonable alternative for selected low-risk patients given the small absolute difference (<0.2%).

Bruno Meduri, Antonella Baldissera, Cinzia Iotti, Luc J E E Scheijmans, Marcel R Stam, Salvatore Parisi, Liesbeth J Boersma, Ilario Ammendolia, Eveline Koiter, Paola Canino, Dianne M Busz, Marika Stenfert Kroese, Patrizia Giacobazzi, Maria P Ruggieri, Antoine Engelen, Tindara Munafò, Karolien Verhoeven, Mariacarla Valli, Roberto Vicini, Riccardo Cuoghi Costantini, Elisa D'Angelo, Frank Lohr, Roberto D'Amico, Giovanni Frezza, Philip Poortmans

This is one of 33,000+ journals available on OSLR. Try it free for 14 days.

Free 14-day trial. 33,000+ journals. Cancel anytime.

14-day free trial. No commitment.

More from Journal of clinical oncology : official journal of the American Society of Clinical Oncology

View all →

Nov 20, 2026 · Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Effect of a Multidisciplinary Intervention on Fatigue in Lymphoma Survivors With Persistent Fatigue: A Randomized Controlled Trial (the REFUEL trial).

Nov 20, 2026 · Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Alectinib as Neoadjuvant Treatment in Potentially Resectable Stage III Anaplastic Lymphoma Kinase-Positive Non-Small Cell Lung Cancer: ALNEO Phase II Trial (GOIRC-01-2020-ML42316).

Nov 20, 2026 · Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Reach of State-Mandated Insurance Coverage for Fertility Preservation in Patients With Cancer.

Nov 13, 2026 · Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Dasatinib Dose Optimization With Weekend Drug Holiday for Improved Tolerability in Chronic Myeloid Leukemia (DasaHIT): A German Chronic Myeloid Leukemia Alliance Randomized Trial.

Nov 13, 2026 · Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Early Treatment Failure in Patients With Relapsed/Refractory Multiple Myeloma Receiving Bispecific T-Cell Engagers: Development and Validation of the CHARGE Prognostic Index.

Nov 12, 2026 · Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Second Cancer Risk in Female Survivors of Hodgkin Lymphoma: A National Cohort Analysis Across Treatment Eras.

“

"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."

Dr. Jennifer Thompson

Dr. Jennifer Thompson

Portland, OR

Stay current without falling behind

33,000+ journals. 3-minute audio summaries. Free for 14 days.

Download on the App StoreGet it on Google Play